Cost-utility analysis of treating mild stage normal tension glaucoma by surgery in China: a decision-analytic Markov model

Table 2 Costs of Treatment in Clinical Management of Normal Tension Glaucoma

Cost input	US Costs in Nominal US Dollars as of 2023	Source
Treatment A
The annual cost of dual therapy*	307.24	Tertiary hospital
The annual cost of triple therapy†	470.45	Tertiary hospital
Cost of trabeculectomy	530.97	Tertiary hospital
Cost of follow-up in no progression patients	79.55	Tertiary hospital
Cost of follow-up in progress patients	119.32	Tertiary hospital
Treatment B
First year cost of moderate stage	381.84	Tang et al. [23]
First year cost of severe stage	381.84	Tang et al. [23]
Cost of the moderate stage in consecutive years of follow-up	254.56	Tang et al. [23]
Cost of the severe stage in consecutive years of follow-up	254.56	Tang et al. [23]

^* Annual cost of dual therapy was the sum of the mild costs of timolol and latanoprost
^† Annual cost of triple therapy was the sum of the annual cost of dual therapy plus the mild cost of a third medication, which was taken as the average mild cost of Azopt, Trusopt, and Alphagan-P

ISSN: 1478-7547